跳至主要内容
临床试验/NCT03048682
NCT03048682已完成不适用

Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery

The Cleveland Clinic2 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2017年1月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
64
试验地点
2
主要终点
Failed Office Voiding Trials

研究概览

简要总结

This study is a randomized controlled trial designed to assess the rate of failure of voiding trials in the early and late post-operative period within patients who underwent outpatient pelvic floor surgery that failed initial same day voiding trials.

详细描述

This study would be powered to detect differences in UTIs and Foley catheter re-insertion rates. Assuming a 10% drop-out rate, 100 total subjects should be enrolled in the study.

All patients that meet the appropriate inclusion criteria and are scheduled for outpatient pelvic floor surgery will be considered for the study. Patients will be counseled about the study either in the office during a surgical planning office visit, over a pre-operative telephone call, or in the pre-operative area just prior to surgery. Consents will be signed in the pre-operative area.

After surgery, the patient will be given a standardized voiding trial as per the usual protocol. If the patient is un-successful in emptying her bladder she will be discharged home with an indwelling Foley catheter with antibiotics. On post-operative day (POD) #1 the patient will be re-assessed for meeting eligibility requirements and will be called and randomized to either the early voiding trial group (EVT) or the late voiding trial group (LVT). Subjects in EVT will be scheduled for a repeat VT on POD#2, POD#3, or POD#4, whereas those in LVT will be scheduled for a repeat VT on or after POD#7. Subjects that are unsuccessful in the repeat VT will have a Foley catheter re-inserted and will return for another VT in 5-7 days. Subjects who fail the third VT from either group will have the Foley catheter replaced and will return for another office VT after waiting an additional 5-7 days or will be started on clean intermittent self-catheterization.

Subjects will be monitored for a 6 week period for voiding and urinary symptoms. Urine will be tested via in-office urinalysis at each office visit, including pre-operatively, and will be sent for a urine culture per usual practice based upon abnormal urinalysis results. Urine cultures that grow out a single organism >10,000 CFU will be treated with appropriate antibiotics. In addition, patients will complete quality of life questionnaires at the time of catheter removal, the standard 2 week post-op visit and at 6weeks post-operatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Female patients
  • •Over 18 years old
  • •Speak English and are capable of giving informed consent and are able to complete the English patient questionnaire
  • •Are willing to return to the office for all necessary visits associated with the study
  • •Had outpatient gynecology pelvic floor surgery for prolapse or stress urinary incontinence
  • •Failed the voiding trial in the recovery room
  • •Discharged to home on POD#0

排除标准

  • •Pre-operative urinary retention as defined as PVR > 200ml
  • •Prior incontinence surgery
  • •Passed the voiding trial in the recovery room
  • •Require prolonged catheterization due to urethral/bladder abnormality (ie vesicovaginal fistula, urethral diverticulum) or intra-op urethral or bladder injury or for intensive post-operative monitoring
  • •Patients who take any post-operative antibiotics, other than prophylaxis during catheterization, for reasons other than a UTI as diagnosed and prescribed as part of the study
  • •Patients who take any supplements to prevent UTIs, including but not limited to D-Mannose, Hiprex, or Ellura
  • •Receive any post-operative vaginal estrogen during the study period
  • •Have any neurological conditions that may affect bladder function (ie. Multiple sclerosis, spinal cord injuries, etc.)
  • •Patients with pre-operative narcotic medication use due to chronic pain
  • •Patients who take any over-active bladder medication within one week of their surgery

研究组 & 干预措施

Early Voiding Trial

Experimental

All subjects that are discharged home with a Foley catheter will need an in-office repeat voiding trial.

Subjects in this group will have their repeat voiding trial on post-op day #2, 3, or 4

干预措施: Foley catheter - Early Voiding Trial (Device)

Late Voiding Trial

Active Comparator

All subjects that are discharged home with a Foley catheter will need an in-office repeat voiding trial.

Subjects in this group will have their repeat voiding trial on post-op day #7 or after. This is our current practice.

干预措施: Foley catheter - Late Voiding Trial (Device)

结局指标

主要结局

Failed Office Voiding Trials

时间窗: within 8 days of surgery

Determine the rates of failed voiding trials in each of the two groups

次要结局

  • Rate of Bother From Urinary Catheter(within 6 weeks of surgery)
  • Urinary Tract Infections(within 6 weeks of surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Hurtado

Investigator

The Cleveland Clinic

研究点 (2)

Loading locations...

相似试验